All lobbying filings

SMITH & NEPHEW, INC.

Lobbying for SMITH & NEPHEW, INC.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $420,000.00 expenses · posted Apr 20, 2026

Official filing document

Bills named in this filing 4

HR 5768
Skin Substitute Access and Payment Reform Act
S 2561
Skin Substitute Access and Payment Reform Act of 2025
HR 6852
Advanced Wound Care and Regenerative Medicine Access and Reform Act
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 4

Medicare/Medicaid

Medicare physician fee schedule and Medicare hospital outpatient rule, issues related to skin substitutes. Issues related to Medicare local coverage determinations for skin substitutes. H.R. 5768 / S. 2561, Skin Substitute Access and Payment Reform Act of 2025. H.R. 6852 Advanced Wound Care and Regenerative Medicine Access and Reform Act. Issues related to APNRM on Ensuring Safety Through Domestic Security With Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement by Medicare Participating Hospitals.

Taxation/Internal Revenue Code

Issues related to section 899 of the One Big Beautiful Bill Act, H.R.1.

Trade (domestic/foreign)

Issues related to tariffs. Issues related to the USMCA trade agreement.

Defense

Educate key government stakeholders on Smith+Nephew products applicable to the military and seek support for appropriations requests.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.